OS Therapies IncorporatedOSTXNYSE
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank75
3Y CAGR-89.0%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-89.0%/yr
Annual compound
Percentile
P75
Within normal range
vs 3Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | 254.71% |
| 2023 | -2.87% |
| 2022 | -23.27% |
| 2021 | 188922.96% |
| 2020 | 0.00% |